Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice

Shinji Tanaka, Yuki Sugiura, Hisako Saito, Mai Sugahara, Yoshiki Higashijima, Junna Yamaguchi, Reiko Inagi, Makoto Suematsu, Masaomi Nangaku, Tetsuhiro Tanaka

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

It is unclear whether long-term sodium-glucose cotransporter 2 (SGLT2) inhibition such as that during the treatment of diabetes has deleterious effects on the kidney. Therefore, we first sought to determine whether abnormal glucose metabolism occurs in the kidneys of 22-week-old BTBR ob/ob diabetic mice. Second, the cumulative effect of chronic SGLT2 inhibition by ipragliflozin and 30% calorie restriction, either of which lowered blood glucose to a similar extent, on renal glucose metabolism was evaluated. Mass spectrometry-based metabolomics demonstrated that these diabetic mice exhibited an abnormal elevation in the renal pools of tricarboxylic acid cycle metabolites. This was almost completely nullified by SGLT2 inhibition and calorie restriction. Moreover, imaging mass spectrometry indicated an increased level of the tricarboxylic acid cycle intermediate, citrate, in the cortex of the diabetic mice. SGLT2 inhibition as well as calorie restriction almost completely eliminated citrate accumulation in the cortex. Furthermore, imaging mass spectrometry revealed that the accumulation of oxidized glutathione in the cortex of the kidneys, prominent in the glomeruli, was also canceled by SGLT2 inhibition and calorie restriction. Effects of these beneficial interventions were consistent with improvements in glomerular damage, such as albuminuria, glomerular hyperfiltration, and mesangial expansion. Tubulointerstitial macrophage infiltration and fibrosis were ameliorated only by calorie restriction, which may have been due to autophagy activation, which was observed only with calorie restriction. Thus, chronic SGLT2 inhibition is efficient in normalizing the levels of accumulated tricarboxylic acid cycle intermediates and increased oxidative stress in the kidneys of diabetic mice.

Original languageEnglish
Pages (from-to)912-925
Number of pages14
JournalKidney International
Volume94
Issue number5
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Sodium-Glucose Transport Proteins
Oxidative Stress
Kidney
Glucose
Citric Acid Cycle
Mass Spectrometry
Citric Acid
Kidney Cortex
Albuminuria
Metabolomics
Glutathione Disulfide
Autophagy
Blood Glucose
Fibrosis
Macrophages

Keywords

  • albuminuria
  • diabetes
  • diabetic nephropathy
  • oxidative stress

ASJC Scopus subject areas

  • Nephrology

Cite this

Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice. / Tanaka, Shinji; Sugiura, Yuki; Saito, Hisako; Sugahara, Mai; Higashijima, Yoshiki; Yamaguchi, Junna; Inagi, Reiko; Suematsu, Makoto; Nangaku, Masaomi; Tanaka, Tetsuhiro.

In: Kidney International, Vol. 94, No. 5, 01.11.2018, p. 912-925.

Research output: Contribution to journalArticle

Tanaka, S, Sugiura, Y, Saito, H, Sugahara, M, Higashijima, Y, Yamaguchi, J, Inagi, R, Suematsu, M, Nangaku, M & Tanaka, T 2018, 'Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice', Kidney International, vol. 94, no. 5, pp. 912-925. https://doi.org/10.1016/j.kint.2018.04.025
Tanaka, Shinji ; Sugiura, Yuki ; Saito, Hisako ; Sugahara, Mai ; Higashijima, Yoshiki ; Yamaguchi, Junna ; Inagi, Reiko ; Suematsu, Makoto ; Nangaku, Masaomi ; Tanaka, Tetsuhiro. / Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice. In: Kidney International. 2018 ; Vol. 94, No. 5. pp. 912-925.
@article{ea72dcd3e07345a484765caa19b6fcf5,
title = "Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice",
abstract = "It is unclear whether long-term sodium-glucose cotransporter 2 (SGLT2) inhibition such as that during the treatment of diabetes has deleterious effects on the kidney. Therefore, we first sought to determine whether abnormal glucose metabolism occurs in the kidneys of 22-week-old BTBR ob/ob diabetic mice. Second, the cumulative effect of chronic SGLT2 inhibition by ipragliflozin and 30{\%} calorie restriction, either of which lowered blood glucose to a similar extent, on renal glucose metabolism was evaluated. Mass spectrometry-based metabolomics demonstrated that these diabetic mice exhibited an abnormal elevation in the renal pools of tricarboxylic acid cycle metabolites. This was almost completely nullified by SGLT2 inhibition and calorie restriction. Moreover, imaging mass spectrometry indicated an increased level of the tricarboxylic acid cycle intermediate, citrate, in the cortex of the diabetic mice. SGLT2 inhibition as well as calorie restriction almost completely eliminated citrate accumulation in the cortex. Furthermore, imaging mass spectrometry revealed that the accumulation of oxidized glutathione in the cortex of the kidneys, prominent in the glomeruli, was also canceled by SGLT2 inhibition and calorie restriction. Effects of these beneficial interventions were consistent with improvements in glomerular damage, such as albuminuria, glomerular hyperfiltration, and mesangial expansion. Tubulointerstitial macrophage infiltration and fibrosis were ameliorated only by calorie restriction, which may have been due to autophagy activation, which was observed only with calorie restriction. Thus, chronic SGLT2 inhibition is efficient in normalizing the levels of accumulated tricarboxylic acid cycle intermediates and increased oxidative stress in the kidneys of diabetic mice.",
keywords = "albuminuria, diabetes, diabetic nephropathy, oxidative stress",
author = "Shinji Tanaka and Yuki Sugiura and Hisako Saito and Mai Sugahara and Yoshiki Higashijima and Junna Yamaguchi and Reiko Inagi and Makoto Suematsu and Masaomi Nangaku and Tetsuhiro Tanaka",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.kint.2018.04.025",
language = "English",
volume = "94",
pages = "912--925",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice

AU - Tanaka, Shinji

AU - Sugiura, Yuki

AU - Saito, Hisako

AU - Sugahara, Mai

AU - Higashijima, Yoshiki

AU - Yamaguchi, Junna

AU - Inagi, Reiko

AU - Suematsu, Makoto

AU - Nangaku, Masaomi

AU - Tanaka, Tetsuhiro

PY - 2018/11/1

Y1 - 2018/11/1

N2 - It is unclear whether long-term sodium-glucose cotransporter 2 (SGLT2) inhibition such as that during the treatment of diabetes has deleterious effects on the kidney. Therefore, we first sought to determine whether abnormal glucose metabolism occurs in the kidneys of 22-week-old BTBR ob/ob diabetic mice. Second, the cumulative effect of chronic SGLT2 inhibition by ipragliflozin and 30% calorie restriction, either of which lowered blood glucose to a similar extent, on renal glucose metabolism was evaluated. Mass spectrometry-based metabolomics demonstrated that these diabetic mice exhibited an abnormal elevation in the renal pools of tricarboxylic acid cycle metabolites. This was almost completely nullified by SGLT2 inhibition and calorie restriction. Moreover, imaging mass spectrometry indicated an increased level of the tricarboxylic acid cycle intermediate, citrate, in the cortex of the diabetic mice. SGLT2 inhibition as well as calorie restriction almost completely eliminated citrate accumulation in the cortex. Furthermore, imaging mass spectrometry revealed that the accumulation of oxidized glutathione in the cortex of the kidneys, prominent in the glomeruli, was also canceled by SGLT2 inhibition and calorie restriction. Effects of these beneficial interventions were consistent with improvements in glomerular damage, such as albuminuria, glomerular hyperfiltration, and mesangial expansion. Tubulointerstitial macrophage infiltration and fibrosis were ameliorated only by calorie restriction, which may have been due to autophagy activation, which was observed only with calorie restriction. Thus, chronic SGLT2 inhibition is efficient in normalizing the levels of accumulated tricarboxylic acid cycle intermediates and increased oxidative stress in the kidneys of diabetic mice.

AB - It is unclear whether long-term sodium-glucose cotransporter 2 (SGLT2) inhibition such as that during the treatment of diabetes has deleterious effects on the kidney. Therefore, we first sought to determine whether abnormal glucose metabolism occurs in the kidneys of 22-week-old BTBR ob/ob diabetic mice. Second, the cumulative effect of chronic SGLT2 inhibition by ipragliflozin and 30% calorie restriction, either of which lowered blood glucose to a similar extent, on renal glucose metabolism was evaluated. Mass spectrometry-based metabolomics demonstrated that these diabetic mice exhibited an abnormal elevation in the renal pools of tricarboxylic acid cycle metabolites. This was almost completely nullified by SGLT2 inhibition and calorie restriction. Moreover, imaging mass spectrometry indicated an increased level of the tricarboxylic acid cycle intermediate, citrate, in the cortex of the diabetic mice. SGLT2 inhibition as well as calorie restriction almost completely eliminated citrate accumulation in the cortex. Furthermore, imaging mass spectrometry revealed that the accumulation of oxidized glutathione in the cortex of the kidneys, prominent in the glomeruli, was also canceled by SGLT2 inhibition and calorie restriction. Effects of these beneficial interventions were consistent with improvements in glomerular damage, such as albuminuria, glomerular hyperfiltration, and mesangial expansion. Tubulointerstitial macrophage infiltration and fibrosis were ameliorated only by calorie restriction, which may have been due to autophagy activation, which was observed only with calorie restriction. Thus, chronic SGLT2 inhibition is efficient in normalizing the levels of accumulated tricarboxylic acid cycle intermediates and increased oxidative stress in the kidneys of diabetic mice.

KW - albuminuria

KW - diabetes

KW - diabetic nephropathy

KW - oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=85051342323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051342323&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2018.04.025

DO - 10.1016/j.kint.2018.04.025

M3 - Article

C2 - 30021702

AN - SCOPUS:85051342323

VL - 94

SP - 912

EP - 925

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -